
|Videos|May 29, 2013
The 340B Drug Discount Program
Adam J. Fein describes how the 340B program is being exploited by many hospital systems due to a lack of oversight by government agencies.
Advertisement
In this video, Adam J. Fein describes how the 340B program is being exploited by many hospital systems due to a lack of oversight by government agencies.
For more information about Dr. Fein's controversial op-ed on 340B pricing, see
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Glucodensity Analysis Enhances CGM Accuracy for Detecting Cystic Fibrosis–Related Diabetes
4
Influenza Burden Among Agricultural Households Highlights Need for Broader Vaccination Programs
5














































































































































































































